Mechanism and in vitro release kinetic study of sirolimus from a biodegradable polymeric matrix coated cardiovascular stent

Industrial and Engineering Chemistry Research

Volumn 50, Issue 16, 2011, Pages 9539-9549

  Raval, Ankur ^a   Parikh, Jigisha ^a   Engineer, Chhaya ^b  

^a SARDAR VALLABHBHAI NATIONAL INSTITUTE OF TECHNOLOGY   (India)

^b Sahajanand Medical Technologies Pvt Ltd   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EVENTS; BIOLOGICAL FLUIDS; CARDIOVASCULAR STENTS; DRUG DELIVERY VEHICLES; DRUG DISSOLUTION; DRUG ELUTION; DRUG RELEASE; DRUG RELEASE KINETICS; DRUG RELEASE MECHANISM; DRUG-ELUTING STENTS; HUMAN HEALTH; IN-VITRO; INFLAMMATORY REACTION; KINETIC STUDY; MEDICINAL APPLICATIONS; METALLIC STENTS; MULTIPLE LAYERS; POLY VINYL PYRROLIDONE; POLYMERIC MATRICES; PROTECTIVE LAYERS; SIROLIMUS; THERAPEUTIC DRUGS; TOP-COATS;

BIOCOMPATIBILITY; BIOLOGICAL MATERIALS; CONTROLLED DRUG DELIVERY; DISSOLUTION; DRUG PRODUCTS; ENGINEERING RESEARCH; FUNCTIONAL POLYMERS; HEALTH CARE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KINETIC THEORY; KINETICS; MATHEMATICAL MODELS; PLASTIC COATINGS; SCANNING ELECTRON MICROSCOPY; SURFACE MORPHOLOGY;

BIODEGRADABLE POLYMERS;

EID: 80051724261     PISSN: 08885885     EISSN: 15205045     Source Type: Journal    
DOI: 10.1021/ie102163z     Document Type: Article

References (34)

1. Morice, M.; Serruys, P.; Sousa, J.; Fajadet, J.; Hayashi, E.; Perin, M.; Colombo, A.; Schuler, G.; Barragan, P.; Guagliumi, G.; Molnàr, F.; Falotico, R. A randomized comparison of a Sirolimus-Eluting Stent with a standard stent for coronary revascularization N. Engl. J. Med. 2002, 346, 1773-80 (Pubitemid 34586912)
2. Van Der Hoeven, B.; Pires, N. M.; Warda, H. M.; Oemrawsingh, P. V.; Van Vlijmen, B.; Quax, P. H.; Schalij, M. J.; Van Der Wall, E. E.; Jukema, J. W. Drug-eluting stents: results, promises and problems Int. J. Cardiol. 2005, 99, 9-17 (Pubitemid 40261018)
3. Bennett, M. R.; OSullivan, M. Mechanisms of angioplasty and stent restenosis: implications for design of rational therapy Pharmacol. Ther. 2001, 91, 149-166 (Pubitemid 33139799)
4. Ip, J. H.; Fuster, V.; Badimon, L.; Badimon, J.; Taubman, M. B.; Chesebro, J. H. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle proliferation J. Am. Coll. Cardiol. 1990, 15, 1667-1687 (Pubitemid 20174335)
5. Spier, E.; Huang, E. S.; Modali, R. Interaction of human cytomegalovirus with p53: possible role in coronary restenosis Scand. J. Infect. Dis., Suppl. 1995, 99, 78-91
6. Bennett, M. R. In-Stent Stenosis: Pathology and Implications for the Development of Drug Eluting Stents Heart 2003, 89, 218-224 (Pubitemid 36115115)
7. Sousa, J. E.; Costa, M. A.; Abizaid, A.; Abizaid, A. S.; Feres, F.; Pinto, I. M. F. Lack of neointimal proliferation after implantation of Sirolimus coated stents in human coronary arteries: a quantitative coronary angiography and 3-dimensional intravascular ultrasound study Circulation 2001, 103, 192-195 (Pubitemid 32095401)
8. Stone, G. W.; Ellis, S. G.; Cox, D. A.; Hermiller, J.; OShaughnessy, C.; Mann, J. T. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N. Engl. J. Med. 2004, 350, 221-231 (Pubitemid 38067635)
9. Moses, J. W.; Leon, M. B.; Popma, J. J.; Fitzgerald, P. J.; Holmes, D. R.; OShaughnessy, C.; Caputo, R. P.; Kereiakes, D. J; Williams, D. O.; Teirstein, P. S.; Jaeger, J. L.; Kuntz, R. E. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N. Engl. J. Med. 2003, 349, 1315-1323 (Pubitemid 37186209)
10. Marx, S. O.; Jayaraman, T.; Go, L. O.; Marks, A. R. Rapamycin-FKBP Inhibits Cell Cycle Regulators of Proliferation in Vascular Smooth Muscle Cells Circ. Res. 1995, 76, 412-417
11. Poon., M.; Marx, S. O.; Gallo, R. Rapamycin inhibits vascular smooth muscle cell migration J. Clin. Invest. 1996, 98, 2777-2783
12. Pham, S. M.; Shears, L. L.; Kawaharda, N. High local production of nitric oxide as a possible mechanism by which rapamycin prevents transplant arteriosclerosis Transplant. Proc. 1998, 30, 953-954 (Pubitemid 28309437)
13. Poston, R. S.; Billingham, M.; Hoyt, E. G. Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model Circulation 1999, 100, 67-74 (Pubitemid 29297942)
14. Gregory, C. R.; Huang, X.; Pratt, R. E. Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement Transplantation 1995, 59, 655-661
15. Gallo, R.; Padurean, A.; Jayaraman, T. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle Circulation 1999, 99, 2164-2170 (Pubitemid 29196802)
16. Acharya, G.; Park, K. Mechanisms of controlled drug release from drug-eluting stents Adv. Drug Delivery Rev. 2006, 58, 387-401 (Pubitemid 43816741)
17. Virmani, R.; Guagliumi, G.; Farb, A. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious? Circulation 2004, 109, 701-705 (Pubitemid 38222887)
18. Buszman, P.; Trznadel, S.; Milewski, K.; Rzezniczak, J.; Przewlocki, T.; Kosmider, M. Novel paclitaxel-eluting, biodegradable polymer coated stent in the treatment of de novo coronary lesions: a prospective multicenter registry Catheter Cardiovasc. Interv. 2008, 71, 51-57 (Pubitemid 351158346)
19. Domb, A.; Amselem, S.; Shah, J.; Maniar, M. Degradable polymers for site-specific drug delivery Polym. Adv. Technol. 2003, 3 (6) 279-292
20. Costa, R. A.; Lansky, A. J.; Abizaid, A.; Müeller, R.; Tsuchiya, Y.; Mori, K. Angiographic results of the first human experience with the Biolimus A9 drug-eluting stent for de novo coronary lesions Am. J. Cardiol. 2006, 98, 443-436
21. Byrne, R. A.; Kastrati, A.; Kufner, S. Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: The Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus- Eluting Stents (ISAR-TEST-4) Trial Eur. Heart J. 2009, 30 (20) 2441-2449
22. Donohoe, D. CYPHER Sirolimus-eluting Stent, PMA # P020026, 2002.
23. Sousa, J. E.; Costa, M. A.; Abizaid, A.; Abizaid, A. S.; Feres, F.; Pinto, I. M. F.; Seixas, A. C.; Staico, R.; Mattos, L. A.; Sousa, A. G. M. R.; Falotico, R.; Jaeger, J.; Popma, J. J.; Serruys, P. W. Lack of Neointimal Proliferation After Implantation of Sirolimus-Coated Stents in Human Coronary Arteries A Quantitative Coronary Angiography and Three-Dimensional Intravascular Ultrasound Study Circulation 2001, 103, 192-195 (Pubitemid 32095401)
24. Van Der Giessen, W. J.; Sorop, O.; Serruys, P. W.; Peters-Krabbendam, I.; Van Beusekom, H. M. M. Lowering the Dose of Sirolimus, Released From a Nonpolymeric Hydroxyapatite Coated Coronary Stent, Reduces Signs of Delayed Healing J. Am. Coll. Cardiol. Intv. 2009, 2, 284-290
25. Balakrishnan, B.; Dooley, J. F.; Kopia, G.; Edelman, E. R. Intravascular drug release kinetics dictate arterial drug deposition, retention, and distribution J. Controlled Release 2007, 123, 100-108 (Pubitemid 47562135)
26. Higuchi, T. Rate of release of medicaments from ointment bases containing drugs in suspension J. Pharm. Sci. 1961, 50, 874-875
27. Korsmeyer, R. W.; Gurny, R.; Doelker, E. M.; Buri, P.; Peppas, N. A. Mechanism of solute release from porous hydrophilic polymers Int. J. Pharm. 1983, 15, 25-35 (Pubitemid 13092121)
28. Peppas, N. A. Analysis of Fickian and non-Fickian drug release from polymers Pharm. Acta Helv. 1985, 60, 110-111
29. Jeong, S. I.; Kim, S. H.; Kim, Y. H.; Jung, Y.; Kwon, J. H.; Kim, B.-S.; Lee, Y. M. Manufacture of elastic biodegradable PLCL scaffolds for mechano-active vascular tissue engineering J. Biomater. Sci., Polym. Ed. 2004, 15 (5) 645-660 (Pubitemid 38842405)
30. Raval, A.; Parikh, J.; Engineer, C. Dexamethasone eluting biodegradable polymeric matrix coated stent for intravascular drug delivery. Chem. Eng. Res. Des. 2010, doi: 10.1016/j.cherd.2010.03.007
31. Serruys, P. W.; Sianos, G.; Abizaid, A. The effect of variable dose and release kinetics on neo-intimal hyperplasia using a novel paclitaxel eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES) J. Am. Coll. Cardiol. 2005, 46, 253-260 (Pubitemid 40966852)
32. Raval, A. J.; Parikh, J. Engineer, C. Mechanism of controlled release kinetics from medical devices Braz. J. Chem. Eng. 2010, 27 (2) 211-225
33. Raval, A.; Choubey, A. Engineer, C.; Kotadia, H.; Kothwala, D. Novel biodegradable polymeric matrix coated cardiovascular stent for controlled drug delivery. Trends Biomater Artif. Organs 2007, Vol 20 (2) 101-110
34. Moore, J. W.; Flanner, H. H. Mathematical comparison of dissolution profiles Pharm. Technol. 1996, 20, 64-74 (Pubitemid 126450495)